Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
HMPL-415
i
Other names:
HMPL-415, HMPL-415S1, HMPL415, HMPL 415, HMPL415S1, HMPL 415S1
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Hutchmed
Drug class:
PTPN11 inhibitor
Related drugs:
‹
ERAS-601 (9)
SHP099 (6)
TNO155 (6)
RMC-4630 (6)
PF-07284892 (4)
BMS-986466 (3)
RMC-4550 (2)
HBI-2376 (1)
JAB-3312 (1)
hexachlorophene (1)
RLY-1971 (1)
BPI-442096 (0)
BR790 (0)
ETS-001 (0)
ICP-189 (0)
sulforafan alfadex (0)
Undisclosed SHP2 inhibitor (0)
ERAS-601 (9)
SHP099 (6)
TNO155 (6)
RMC-4630 (6)
PF-07284892 (4)
BMS-986466 (3)
RMC-4550 (2)
HBI-2376 (1)
JAB-3312 (1)
hexachlorophene (1)
RLY-1971 (1)
BPI-442096 (0)
BR790 (0)
ETS-001 (0)
ICP-189 (0)
sulforafan alfadex (0)
Undisclosed SHP2 inhibitor (0)
›
Associations
News
Trials
Filter by
Latest
over1year
A Study of HMPL-415S1 in Patients With Advanced Malignant Solid Tumors (clinicaltrials.gov)
P1, N=81, Recruiting, Hutchmed | Not yet recruiting --> Recruiting
over 1 year ago
Enrollment open • Metastases
|
KRAS (KRAS proto-oncogene GTPase)
|
KRAS mutation
|
HMPL-415
over1year
A Study of HMPL-415S1 in Patients With Advanced Malignant Solid Tumors (clinicaltrials.gov)
P1, N=81, Not yet recruiting, Hutchmed
over 1 year ago
New P1 trial • Metastases
|
KRAS (KRAS proto-oncogene GTPase)
|
KRAS mutation
|
HMPL-415
Share via
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login